AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9844307 — intervention group
Group type: EXPERIMENTAL
Intervention: Three tests (vibration, electric current, thermal perception)
Number of subjects: 53
Study 9844307 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of vibration exposure
Number of subjects: 53
Study 9844307 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of work exposure
Number of subjects: 53
Study 8005300 — intervention group
Group type: EXPERIMENTAL
Intervention: RU486 (1 mg/d for 5 days)
Number of subjects: 0
Study 8005300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3178922 — intervention group
Group type: EXPERIMENTAL
Intervention: Enciprazine
Number of subjects: 0
Study 3178922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31899117 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography-guided corticosteroid injection (CI)
Number of subjects: 44
Study 31899117 — intervention group
Group type: COMPARATOR
Intervention: Blind corticosteroid injection (CI)
Number of subjects: 44
Study 31899117 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography-guided CI
Number of subjects: 44
Study 31899117 — intervention group
Group type: COMPARATOR
Intervention: Blind CI
Number of subjects: 44
Study 31307535 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 206
Study 31307535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study 28368486 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile GnRH therapy administered subcutaneously for 3 months
Number of subjects: 40
Study 28368486 — intervention group
Group type: COMPARATOR
Intervention: Pulsatile GnRH therapy
Number of subjects: 40
Study 26637582 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Vitamin A (VA)
Number of subjects: 30
Study 24026893 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate 1000 mg daily + cholecalciferol 1600 IU daily
Number of subjects: 150
Study 24026893 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate 1000 mg daily
Number of subjects: 150
Study 21566104 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (Mabthera, 375 mg/m² intravenously) with lower doses of prednisone and calcineurin inhibitors
Number of subjects: 54
Study 21566104 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (current therapy alone)
Number of subjects: 54
Study 18197434 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ceftriaxone
Number of subjects: 96
Study 18197434 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral moxifloxacin
Number of subjects: 96
Study 18197434 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 96
Study 16040117 — intervention group
Group type: COMPARATOR
Intervention: Single-step impression technique
Number of subjects: 0
Study 16040117 — intervention group
Group type: COMPARATOR
Intervention: Monophase impression technique
Number of subjects: 0
Study 16040117 — intervention group
Group type: COMPARATOR
Intervention: Two-step impression technique
Number of subjects: 0
Study 16040117 — intervention group
Group type: EXPERIMENTAL
Intervention: Impression techniques
Number of subjects: 0
Study 16040117 — intervention group
Group type: EXPERIMENTAL
Intervention: Position of the preparation margin
Number of subjects: 0
Study 12548298 — intervention group
Group type: COMPARATOR
Intervention: Apple drink (25% fruit juice)
Number of subjects: 21
Study 12548298 — intervention group
Group type: EXPERIMENTAL
Intervention: TCP dispersed in water containing 1200 mg Ca
Number of subjects: 21
Study 12548298 — intervention group
Group type: EXPERIMENTAL
Intervention: HCSM containing 1200 mg Ca and 65.5 mg Mg
Number of subjects: 21
Study 12548298 — intervention group
Group type: EXPERIMENTAL
Intervention: HCSM containing 1200 mg Ca and 172 mg Mg
Number of subjects: 21
Study 12548298 — intervention group
Group type: EXPERIMENTAL
Intervention: High calcium drinks (TCP, HCSM, HCSM+Mg)
Number of subjects: 21
Study 11460290 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Pik Sonic Speed (W)
Number of subjects: 36
Study 11460290 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonicare (S)
Number of subjects: 36
Study 11460290 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (Elmex Super 39, E)
Number of subjects: 36
Study 9297766 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium-89 systemic radiotherapy (single injection)
Number of subjects: 0
Study 8269451 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 220 mg
Number of subjects: 203
Study 8269451 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 203
Study 8269451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 3899046 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (0.15 mg/kg)
Number of subjects: 29
Study 3899046 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (0.3 mg/kg)
Number of subjects: 29
Study 3899046 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (0.6 mg/kg)
Number of subjects: 29
Study 3899046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 30224584 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioral Therapy for Insomnia (CBT-I) consisting of a group session (60 min) and an individual session (30 min)
Number of subjects: 79
Study 30224584 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 79
Study 30224584 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 79
Study 26654214 — intervention group
Group type: EXPERIMENTAL
Intervention: 11-G vacuum-assisted biopsy (VAB)
Number of subjects: 129
Study 26654214 — intervention group
Group type: COMPARATOR
Intervention: 14-G core needle biopsy (CNB)
Number of subjects: 129
Study 26654214 — intervention group
Group type: EXPERIMENTAL
Intervention: Both VAB and CNB
Number of subjects: 129
Study 25504080 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 61
Study 25504080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 22898577 — intervention group
Group type: COMPARATOR
Intervention: Wii Fit training alone (WI group)
Number of subjects: 17
Study 22898577 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy training alone (PT group)
Number of subjects: 17
Study 22898577 — intervention group
Group type: EXPERIMENTAL
Intervention: Both physical therapy and Wii Fit training (PW group)
Number of subjects: 17
Study 22898577 — intervention group
Group type: COMPARATOR
Intervention: Wii Fit training (WI group)
Number of subjects: 17
Study 22898577 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy training (PT group)
Number of subjects: 17
Study 20397024 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 8 kcal/kg/week
Number of subjects: 251
Study 20397024 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 12 kcal/kg/week
Number of subjects: 251
Study 20397024 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 251
Study 17852170 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive behavioral therapy with attention to relapse prevention
Number of subjects: 46
Study 17852170 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study 15668991 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 27
Study 15668991 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 27
Study 15668991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 12414334 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra)
Number of subjects: 0
Study 10078679 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.125% plus 7.5 microg sufentanil
Number of subjects: 130
Study 10078679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.125% plus 7.5 microg sufentanil
Number of subjects: 130
Study 10078679 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.100% plus 7.5 microg sufentanil
Number of subjects: 130
Study 10078679 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125% and Ropivacaine 0.125% with sufentanil
Number of subjects: 130
Study 7743301 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg every morning for 3 weeks)
Number of subjects: 11
Study 7743301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 2040103 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of prednisone for 14 days
Number of subjects: 20
Study 2040103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6165428 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially purified human leucocyte interferon (PIF)
Number of subjects: 0
Study 6165428 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation purified by passage twice through a monoclonal antibody affinity chromatography column (NK21F)
Number of subjects: 0
Study 6165428 — intervention group
Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 0
Study 31759471 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated Knowledge System (CKS)
Number of subjects: 17
Study 31759471 — intervention group
Group type: COMPARATOR
Intervention: Survey plus Practice Guidelines (SPG)
Number of subjects: 17
Study 28137530 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritist 'passe'
Number of subjects: 41
Study 28137530 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 41
Study 28137530 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 41
Study 25995489 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal pain regimen with periarticular injection (PAI)
Number of subjects: 84
Study 25995489 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (PCEA)
Number of subjects: 84
Study 24338139 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (50 μg/kg intravenously followed by 24 hours infusion at 0.5 μg/kg/min)
Number of subjects: 80
Study 24338139 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 80
Study 21357861 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam
Number of subjects: 5
Study 21357861 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolite i2
Number of subjects: 5
Study 21357861 — intervention group
Group type: EXPERIMENTAL
Intervention: Coolex
Number of subjects: 5
Study 21357861 — intervention group
Group type: COMPARATOR
Intervention: Nonisolated control
Number of subjects: 5
Study 20184048 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular repair (endovascular first)
Number of subjects: 600
Study 20184048 — intervention group
Group type: COMPARATOR
Intervention: Open repair (normal care)
Number of subjects: 600
Study 17664328 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) and Lamivudine (3TC) administered once daily (QD)
Number of subjects: 27
Study 17664328 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (ZDV) and Lamivudine (3TC) administered twice daily (BID)
Number of subjects: 27
Study 15222056 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative gastrointestinal decompression
Number of subjects: 368
Study 15222056 — intervention group
Group type: COMPARATOR
Intervention: No postoperative gastrointestinal decompression
Number of subjects: 368
Study 12391662 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery with mesh prosthesis and general anesthesia
Number of subjects: 0
Study 12391662 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study 12391662 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 0
Study 9698958 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemofiltration with saline added in a ratio of 5:1 of estimated blood volume
Number of subjects: 16
Study 9698958 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemofiltration with saline added in a ratio of 1:1 of estimated blood volume
Number of subjects: 16
Study 9698958 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 16
Study 8728789 — intervention group
Group type: EXPERIMENTAL
Intervention: Steatocrit
Number of subjects: 50
Study 8728789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudan III
Number of subjects: 50
Study 8728789 — intervention group
Group type: COMPARATOR
Intervention: Van de Kamer test
Number of subjects: 50
Study 2677227 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified pork insulin (Nordisk, Denmark)
Number of subjects: 29
Study 2677227 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin of recombinant DNA origin (Eli Lilly, USA)
Number of subjects: 29
Study 332471 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 16
Study 332471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31125385 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation at frequencies of 0.5Hz, 1.1Hz, 1.6Hz (each with 500 stimuli)
Number of subjects: 90
Study 31125385 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 90
Study 27809613 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete enteral feed (CEF) with expressed breast milk (EBM), n=51
Number of subjects: 103
Study 27809613 — intervention group
Group type: COMPARATOR
Intervention: Minimal enteral feed (MEF) supplemented with intravenous fluid (IVF), n=52
Number of subjects: 103
Study 25868876 — intervention group
Group type: EXPERIMENTAL
Intervention: TriGuard™ Embolic Deflection Device (EDD)
Number of subjects: 37
Study 24195786 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril (10 - 20 mg once daily)
Number of subjects: 176
Study 24195786 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (5 - 10 mg once daily)
Number of subjects: 176
Study 22428349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 60
Study 22428349 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 60
Study 19957508 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intercostal nerves block-sevoflurane used inhalation anesthesia with laryngeal mask ventilation
Number of subjects: 60
Study 19957508 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane used inhalation anesthesia with laryngeal mask ventilation (Control Group)
Number of subjects: 60
Study 16886116 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin transporter short/short (S/S) genotype
Number of subjects: 54
Study 16886116 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin transporter allele S genotype
Number of subjects: 54
Study 16886116 — intervention group
Group type: EXPERIMENTAL
Intervention: S/S genotype in patients with less than 40% of markers evacuated within 72 h
Number of subjects: 54
Study 16886116 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 54
Study 15549276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa powder (11.6 g)
Number of subjects: 42
Study 15549276 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (19 mg) and theobromine (250 mg) combination
Number of subjects: 42
Study 15549276 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk chocolate (methylxanthine doses)
Number of subjects: 42
Study 15549276 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark chocolate (methylxanthine doses)
Number of subjects: 42
Study 15549276 — intervention group
Group type: COMPARATOR
Intervention: White chocolate
Number of subjects: 42
Study 11510029 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (1,200 mg/m² IV on days 1 and 8) plus Carboplatin (AUC 5 IV on day 1)
Number of subjects: 77
Study 11510029 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (60 mg/m² IV on day 1) plus Etoposide (120 mg/m² IV on day 1 and 100 mg orally on days 2 and 3)
Number of subjects: 77
Study 9242944 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional hemodialysis with elevated modeled V/W ratios (0.64)
Number of subjects: 20
Study 9242944 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis without elevated modeled V/W ratios (0.53)
Number of subjects: 20
Study 9242944 — intervention group
Group type: EXPERIMENTAL
Intervention: Access flow
Number of subjects: 20
Study 9242944 — intervention group
Group type: EXPERIMENTAL
Intervention: Recirculation measurement by slow flow/clamp technique
Number of subjects: 20
Study 9242944 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up modeling in high V/W patients
Number of subjects: 20
Study 8488028 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Number of subjects: 50
Study 8488028 — intervention group
Group type: COMPARATOR
Intervention: Control diet (gluten-free diet supplemented by gluten)
Number of subjects: 50
Study 3320187 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 0
Study 3320187 — intervention group
Group type: COMPARATOR
Intervention: Dothiepin
Number of subjects: 0
Study 28874323 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic and zinc
Number of subjects: 620
Study 28874323 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic and placebo
Number of subjects: 620
Study 28874323 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo and zinc
Number of subjects: 620
Study 28874323 — intervention group
Group type: COMPARATOR
Intervention: Two placebos
Number of subjects: 620
Study 27180949 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching plus manually applied manipulation (MAM)
Number of subjects: 65
Study 27180949 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching plus instrument‐applied manipulation (IAM)
Number of subjects: 65
Study 27180949 — intervention group
Group type: COMPARATOR
Intervention: Stretching (control)
Number of subjects: 65
Study 25150180 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmakinetic enucleation of the prostate (PKEP)
Number of subjects: 310
Study 25150180 — intervention group
Group type: COMPARATOR
Intervention: Plasmakinetic resection of the prostate (PKRP)
Number of subjects: 310
Study 23808896 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care (IC) provided by a multidisciplinary team for 52 weeks
Number of subjects: 196
Study 23808896 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 196
Study 23808896 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care (IC)
Number of subjects: 196
Study 19933225 — intervention group
Group type: EXPERIMENTAL
Intervention: Genous stent
Number of subjects: 193
Study 19933225 — intervention group
Group type: COMPARATOR
Intervention: Taxus stent
Number of subjects: 193
Study 18487758 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Disease Surveillance System for monitoring blood glucose data
Number of subjects: 0
Study 18487758 — intervention group
Group type: COMPARATOR
Intervention: Monitoring blood glucose levels
Number of subjects: 0
Study 16014875 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 302
Study 16014875 — intervention group
Group type: COMPARATOR
Intervention: Job Readiness (JR) (attention control)
Number of subjects: 302
Study 16014875 — intervention group
Group type: COMPARATOR
Intervention: Standard Referral
Number of subjects: 302
Study 12793556 — intervention group
Group type: EXPERIMENTAL
Intervention: Early reconstruction (within 2 weeks)
Number of subjects: 31
Study 12793556 — intervention group
Group type: COMPARATOR
Intervention: Delayed reconstruction (8 to 12 weeks)
Number of subjects: 31
Study 11066188 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational approaches toward a new classification of patients with early synovitis
Number of subjects: 0
Study 11066188 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical treatment approaches
Number of subjects: 0
Study 11066188 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition awareness and manipulation of biological pathways
Number of subjects: 0
Study 9001663 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg/day i.v.)
Number of subjects: 28
Study 9001663 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 28
Study 1619181 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-enriched egg (1 egg/day)
Number of subjects: 103
Study 1619181 — intervention group
Group type: COMPARATOR
Intervention: Diet control (no egg)
Number of subjects: 103
Study 6394004 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor, 250 mg twice daily for 10 days
Number of subjects: 100
Study 6394004 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin, 500 mg four times daily for 10 days
Number of subjects: 100
Study 6394004 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor and Ampicillin (both regimens)
Number of subjects: 100
Study 6394004 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 100
Study 6394004 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 100
Study 29401202 — intervention group
Group type: EXPERIMENTAL
Intervention: One session of plyometric training (1SPT)
Number of subjects: 30
Study 29401202 — intervention group
Group type: COMPARATOR
Intervention: Two sessions of plyometric training (2SPT)
Number of subjects: 30
Study 29401202 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (PT)
Number of subjects: 30
Study 27371157 — intervention group
Group type: COMPARATOR
Intervention: AQW051 100mg
Number of subjects: 68
Study 27371157 — intervention group
Group type: COMPARATOR
Intervention: AQW051 7.5mg
Number of subjects: 68
Study 27371157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 22763117 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip-adductor strengthening programme using elastic bands
Number of subjects: 34
Study 22763117 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study 22392168 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk (either breastfed or bottle-fed) during heel lance
Number of subjects: 71
Study 22392168 — intervention group
Group type: COMPARATOR
Intervention: Sucrose administered before heel lance
Number of subjects: 71